The rating affirmation is based on a number of factors, including Shands’ growing patient volumes, improved financial performance and relationship with Gainesville-based University of Florida College of Medicine.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that Shands will perform in fiscal year 2017 as it did in FY 2016.
More articles on healthcare finance:
Fitch affirms Memorial Sloan Kettering Cancer Center’s ‘AA’ rating
9 recent hospital outlook and credit rating actions
ACA replacement could take years to draft, senator says
